Find every first-time home buyer grant & down payment assistance program in the U.S.

The purpose of this grant is to support research proposals focused on current topics related to Alzheimer's disease and its related dementias. Eligible applicants include public and private higher education institutions, small businesses, nonprofits, government entities, and various organizations serving specific communities. To apply, interested parties should refer to the full opportunity announcement for detailed application instructions.

The Theories, Models and Methods (TMM) initiative aims to support the development of computational tools for understanding dynamic brain circuits, making them accessible to the research community to advance theories, models, and methods related to neural circuit mechanisms. Eligible applicants include nonprofits, government entities, educational institutions, businesses, and other organizations, including foreign entities and tribal governments. Application details are not specified in the provided text; for more information, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

The purpose of this grant is to invite renewal applications for existing NINDS-supported clinical trial cooperative agreement awards (U01) that require additional time and resources to complete their clinical trials. Eligible applicants include public and Indian housing authorities, independent school districts, various federal agencies, faith-based or community-based organizations, and Indian/Native American Tribal Governments, among others; however, non-domestic entities are not eligible. To apply, interested parties should refer to the full opportunity announcement for detailed application instructions and contact NIH Grants Information for further inquiries.

The purpose of this grant is to provide funding for the pre-clinical and early stage clinical development of novel drug candidates aimed at preventing Alzheimer's disease, slowing its progression, or treating its symptoms. Eligible applicants include public and private higher education institutions, government entities, nonprofits, and small businesses, among others. To apply, interested parties should refer to the full opportunity announcement for detailed application instructions.

The grant aims to support the discovery and development of new treatments for mental disorders, substance use disorders, and alcohol use disorder, encouraging partnerships between academia and industry. Eligible applicants include independent school districts, public and private higher education institutions, various nonprofit organizations, government entities, and for-profit businesses. Application details are not specified in the provided text; however, interested parties should refer to the full opportunity announcement for more information.

The purpose of this grant is to support well-planned clinical trials in cancer prevention and control, addressing gaps in information that can hinder trial design and execution. Eligible applicants include small businesses, various educational institutions, state and local governments, nonprofits, and other organizations, including those serving specific communities. To apply, interested parties should refer to the full opportunity announcement for detailed application instructions.

The grant aims to advance the discovery and development of new treatments for mental disorders, substance use disorders, and alcohol use disorder, encouraging partnerships between academia and industry. Eligible applicants include public and private higher education institutions, nonprofits, government entities, and for-profit organizations, among others. Application details are not specified in the provided text, but interested parties should refer to the full opportunity announcement for more information.

The purpose of this grant is to support well-planned clinical trials in cancer prevention and control, addressing gaps in information that can hinder trial design and execution. Eligible applicants include various nonprofit organizations, educational institutions, government entities, small businesses, and other specified groups such as Native American tribal organizations and historically black colleges. Application details are not provided in the description; interested parties should refer to the full opportunity announcement for more information.

The grant aims to provide funding for pharmacodynamic, pharmacokinetic, and in vivo efficacy studies of therapeutic agents intended to treat neurological or neuromuscular disorders, as part of the IGNITE initiative to support initial translational efforts. Eligible applicants include public and private educational institutions, small businesses, nonprofits, various government entities, and other organizations such as tribal colleges and historically black colleges. Application details are not specified in the provided text; interested parties should refer to the full opportunity announcement for further instructions.

The grant aims to support the development and validation of animal models and human/animal tissue ex vivo systems that mimic neurological or neuromuscular disorders, enhancing the translational relevance for neurotherapeutics. Eligible applicants include various government entities, nonprofits, educational institutions, for-profit organizations, and other specified groups. To apply, interested parties should refer to the full opportunity announcement for detailed application instructions.

The grant aims to support research applications focused on developing in vitro and ex vivo assays to identify therapeutic agents for neurological or neuromuscular disorders, as part of the Innovation Grants to Nurture Initial Translational Efforts (IGNITE) initiative. Eligible applicants include various nonprofit organizations, government entities, educational institutions, for-profit organizations, and other specified groups such as tribal governments and minority-serving institutions. Application details can be found in the full opportunity announcement, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.

The CTSA Collaborative and Innovative Acceleration Award (CCIA) aims to enhance translational research by funding the development and implementation of innovative solutions within the CTSA Program Consortium. Eligible applicants include public and state institutions of higher education, while non-domestic entities are not permitted to apply. For application details, refer to the Notice of Funding Opportunity (NOFO).